• [[Translated article]]Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas
• [Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage
• [Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas
• "Next top" mouse models advancing CTCL research
• A Case of Sezary Syndrome in a Patient Treated with Dupilumab for Atopic Dermatitis
• A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab
• A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome
• Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab
• Acute Exfoliative Dermatitis/Erythroderma Secondary to Gliclazide
• Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
• Advances in the pharmacological management of cutaneous T-cell lymphoma
• Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments
• Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
• Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma
• Alopecia areata-like presentations with mogamulizumab therapy
• An occurrence of eosinophilic folliculitis and alopecia associated with a sustained complete response to mogamulizumab in Sezary syndrome: a case report
• Assessing Health-Related Quality of Life in Mycosis Fungoides and Sezary Syndrome: Unmet Needs
• Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sezary Syndrome Compared to a Matched Control Cohort
• Bilateral peripheral ulcerative keratitis in a patient with known Sezary syndrome
• Bridging the specialty gap: Update on primary cutaneous lymphomas
• CD39 is expressed by a wide range of cutaneous T-cell lymphomas
• Changes to Registered and Pivotal Clinical Trials following the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome
• Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study
• Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019
• Chemical exposures and demographic associations in cutaneous T-cell lymphoma: a large single institution physician validated cohort study
• Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review
• Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec
• Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review
• Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features
• Cutaneous Naganishia albida (Cryptococcus albidus) infection: a case report and literature review
• Cutaneous T-cell Lymphoma
• Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
• Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature
• Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis
• Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome
• Delving into the Metabolism of Sezary Cells: A Brief Review
• Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL)
• Dupilumab-Associated Sezary Syndrome
• Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma
• Effectiveness and safety of mogamulizumab for the treatment of Sezary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France
• EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023
• Epidemiologie reifzelliger T- und NK-Zell-Lymphome in Deutschland - Eine repräsentative Querschnittanalyse von GKV-Routinedaten: Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data
• Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region
• Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data
• Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients
• Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
• Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
• Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
• Extracorporeal Photopheresis in Dermatological Diseases
• Fatal acute graft-versus-host disease in Sezary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation
• Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma: A Comparative Analysis of Regimens
• Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome
• Hair repigmentation in Sezary syndrome
• High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome
• Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas
• Immunobiology and treatment of cutaneous T-cell lymphoma
• Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies
• Inflammatory arthritis complicating mogamulizumab treatment of Sézary syndrome
• Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome
• JAAD Game Changers: "Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium"
• JAAD Game Changers: Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the US Cutaneous Lymphoma Consortium
• Journal Club: Mycosis fungoides and Sezary syndrome: an update on a classic disease
• Keratinocytes present Staphylococcus aureus enterotoxins and promote malignant and non-malignant T cell proliferation in cutaneous T cell lymphoma
• Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma
• Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome
• Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
• Mogamulizumab-associated rash - Case series and review of the literature
• Mogamulizumab‐assoziierter Rash – Fallserie und aktuelle Literatur
• New <em>JAK3-INSL3</em> Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma
• On the Way to Curing Advanced-Stage Mycosis Fungoides/Sezary Syndrome
• Paediatric cutaneous lymphomas including rare subtypes: A 40-year experience at a tertiary referral centre
• Pathophysiology of cutaneous T-cell lymphomas: Perspective from a French referral centre
• Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sezary Syndrome (BIO-MUSE): Protocol for a Translational Study
• Predictive and prognostic biomarkers in patients with Mycosis fungoides and Sezary syndrome (BIO-MUSE): Study protocol for a translational study
• Primary cutaneous EBV+ extranodal NK/T-cell lymphoma of gamma/delta T-cell lineage in the posttransplantation setting
• Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates
• Progression of CD8-positive Sezary syndrome from mycosis fungoides following dupilumab treatment
• Quantification of the median fluorescence intensity of CD3 and CD4 in mycosis fungoides/Sezary syndrome versus non-neoplastic control cases in peripheral blood
• Racial Disparities in Mycosis Fungoides/Sezary Syndrome-A Single-Center Observational Study of 292 Patients
• Real-life efficacy of immunotherapy for Sezary syndrome: a multicenter observational cohort study
• Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sezary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study
• Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma
• Sezary syndrome associated vitiligo-like leukoderma in type V skin: Report of a case and review of the literature
• Sezary Syndrome in West Sweden: Exploring Epidemiology, Clinical Features, and Treatment Patterns in a Registry-Based Retrospective Analysis
• Sezary syndrome initially presenting as pityriasis rubra pilaris: Clinicopathologic study of 3 cases
• Sezary Syndrome: A Case Report and Review of Current Therapeutics
• Staphylococcus aureus and Sezary syndrome
• Staphylococcus aureus induce drug resistance in cancer T cells in Sezary Syndrome
• Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas
• The fifth edition of the WHO-Classification - what is new for cutaneous lymphomas?
• The Interferon story continues: EORTC CLTG Study Explores Pegylated Interferon Alpha-2alpha's Role in Treating Mycosis Fungoides/Sezary Syndrome
• The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
• Unleashed monocytic engagement in Sezary syndrome during the combination of anti-CCR4 antibody with type I interferon
• Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T-cell lymphoma on quality of life
• Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify Sezary syndrome patients with low blood burden
• Urticarial mycosis fungoides: A distinctive presentation with blood involvement and a peculiar immunophenotype
• Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
• Varied presentations of primary cutaneous lymphoma: A case series from a tertiary care center in South India
• What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
• Whole-Transcriptome Sequencing-Based Profiling of the Cutaneous Virome in Patients with Secondary Immunodeficiency